A new ACC Scientific Statement addresses the management of obesity in adults with heart failure (HF), with a specific focus on those with stage 2 HF with preserved ejection fraction (HFpEF). It is the first in a new series of clinical guidance from the College aimed at informing clinicians about areas where evidence is new and evolving or where sufficient data are more limited. Read more.
Join ACC's Cardiovascular Imaging Member Section on Tuesday, Aug. 5 at 5:30 p.m. ET for a case-based, multi-modality webinar of the contemporary cardiovascular imaging evaluation of cardiac amyloidosis designed for a broad range of cardiovascular disease clinicians. The webinar will discuss the contemporary multimodality imaging evaluation of cardiac amyloidosis and incorporate relevant clinical cases. Learn more and register.
In The Great GDMT Debates: Heart Failure Hot Takes, heart failure experts defend their views on guideline-directed medical therapy, with special focus on HFpEF + GLP-1 agonists. It's just one of more than a thousand presentations from ACC.25, including inspiring keynotes, cutting-edge late-breaking clinical trials, thought-provoking panels and more. ACC.25 attendees with full three-day conference professional registration receive a FREE one-year subscription to ACC Anywhere – login to activate your account. Didn't attend ACC.25? Enjoy a free preview and subscribe to watch the full video, plus thousands more from ACC's top meetings!
The ACC and Pfizer are collaborating to offer a new grant opportunity, seeking proposals for quality improvement initiatives that will increase identification and accurate diagnosis of heart failure (HF) patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Apply by May 28.
Expand your expertise and maintain your certification with the newly updated HF SAP! The comprehensive online program spans the full spectrum of advanced heart failure (HF) and transplant cardiology, helping you identify knowledge gaps, reinforce essential concepts and stay current with the latest developments in the field. Your 5-year access includes annual updates to reflect emerging science and clinical guidelines including the "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" and the "2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease," plus much more. Additionally, you have the option to meet your MOC requirements through the Collaborative Maintenance Pathway (CMP). Advance your practice and stay certified – learn more today!
Learn best practices and emerging science across practice-changing topics in care, including cardiac arrhythmias, cardiovascular disease prevention, heart failure and cardiomyopathies and vascular diseases with ACC's updated clinical spotlight series. Join leading experts in the field for a series of on-demand, interactive clinical spotlight sessions from ACC.25, including:
Complete all four activities and earn up to 5.25 CME/CNE/CPE/AAPA/MOC/IPCE credits! Start the series.
Save your spot for the next virtual JACC Journal Club on Wednesday, May 21 at 5 p.m. ET, to discuss the latest TTR amyloid research – including HELIOS-B.
Heart failure (HF) is the leading cause of morbidity and mortality for patients with adult congenital heart disease (ACHD), and there is a growing number of ACHD HF patients with medical, anatomic and surgical complexity.
Now is your chance to be a part of ACC Quality Summit 2025, taking place Oct. 14-16 in Denver, CO, and share your quality improvement work using NCDR registries, ACC's Heart Failure Accreditation or other data sources on a national stage. "Quality, registry and analytic expertise are the foundational drivers for clinical transformation," says Eleanor A. Huff, MSN, RN, FACC.
Abstracts are due by May 27 for Live Session consideration and June 23 for ePosters. Plus, watch a webinar with Mary Norine Walsh, MD, MACC, on how your abstract submission can also become a published manuscript in JACC: Case Reports. Submit your abstract today.
Join ACC's Reproductive Health and Cardio-Obstetrics Member Section on Tuesday, May 20 at noon ET for a webinar which will highlight findings from a recent study in JACC: Heart Failure evaluating preeclampsia's role in pregnancy after heart transplant and provide input from a multidisciplinary panel of cardio-obstetrics experts. The session will conclude with a live Q&A featuring a multidisciplinary expert panel. Save your spot.
Expand your expertise in advanced heart failure (HF) and transplant cardiology with the newly updated HF SAP. The comprehensive online program covers the full spectrum of advanced HF and transplant cardiology, helping you identify knowledge gaps, reinforce existing concepts, maintain your certification and stay updated on the latest science and clinical guidance – including the "2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis," a 2024 update to the "2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure," and more! Learn more.
New interactive lessons have launched as part of ACC's online course, Baroreflex Activation Therapy: Optimizing Treatment of Heart Failure, which covers the stages of heart failure (HF) where baroreflex activation therapy (BAT) is effective, including its benefits and limitations for early intervention. The lessons, as well as patient case quizzes and an infographic, discuss criteria for selecting patients for BAT, the synergy between devices and drugs in HF treatment, and the role of a multidisciplinary team in optimizing BAT to improve patient outcomes. Join Maya E. Guglin, MD, FACC, for the interactive lesson on optimizing BAT for heart failure patients and explore the rest of the course!
ACC's new online course, Baroreflex Activation Therapy: Optimizing Treatment of HF, covers the stages of heart failure (HF) where baroreflex activation therapy (BAT) is effective, including its benefits and limitations for early intervention. It also discusses criteria for selecting patients for BAT, the synergy between devices and drugs in HF treatment, and the role of a multidisciplinary team in optimizing BAT to improve patient outcomes. Activities include a patient case quiz and an infographic. Stay tuned as more activities are added this spring. Learn more.
Join Vivek Kulkarni, MD, FACC, on Friday, March 28 from 1-5 p.m. CT, for a pre-conference workshop designed for navigating the world of research and evidence-based guidelines – with special focus on the TAVR-Unload Trial and 2020 ACC/AHA Valve Disease Guideline. Practice applying JACC articles and clinical guidelines to a real-world case, with guidance from expert coaches in the field, including Sandra M. Oliver-McNeil, DNP, ACNP-BC, FACC; Erica Spatz, MD, FACC; and Muthiah Vaduganathan, MD. Register today for ACC.25, taking place March 29-31 in Chicago, and add the JACC Workshop to your registration. Already registered? Login to your attendee dashboard to add the workshop to your registration.
This Heart Failure (HF) Awareness Week, the ACC acknowledges all sites dedicated to streamlining processes and improving quality of care with ACC's Heart Failure Accreditation.
JACC: Heart Failure is seeking original scientific investigations, state-of-the-art reviews and brief reports for an upcoming special focus issue on screening for heart failure. The journal welcomes investigations that examine the role of large population-based screen strategies for detecting and diagnosing heart failure, as well as early initiation of treatment strategies. Learn more and submit your science by April 1.
Join a distinguished panel of judges on Wednesday, Feb. 26 at 7 p.m. ET as they hear young investigators pitch their heart failure (HF) research ideas "Shark Tank" style. See which project has the most potential and learn from our judges the tools one needs to conduct successful research. The webinar will help participants refine their research proposals, enhance their critical appraisal skills and more. Learn more.
The latest advances transforming the field of heart failure (HF) will be on full display with the HF and Cardiomyopathies Learning Pathway at ACC.25. The pathway will take you through everything from optimizing guideline-directed medical therapies to breakthrough developments in heart transplantation – as experts deliver practical, evidence-based strategies for managing complex conditions, including cardiac amyloidosis and hypertrophic cardiomyopathy. Plus, Larry A. Allen, MD, FACC, will present the keynote, "Equity Isn't Just a Buzz Word: Strategies to Improve Access to HF Therapies For ALL Patients." Register here for and the opportunity to explore 300+ sessions at ACC.25, taking place March 29-31 in Chicago, IL!
The ACC recognizes more than 2,000 hospitals and facilities participating in NCDR registries and ACC Accreditation Services, including those participating in Heart Failure Accreditation, in the ACC insert of the 2025 U.S. News and World Report "Best Hospitals" guidebook released Nov. 21. As the global professional home for the entire cardiovascular care team, the ACC is committed to supporting patients, caregivers and health care professionals by ensuring the highest-quality care is delivered to every patient, every time. Explore this year's issue.
There's still time to join your colleagues for the Valentin Fuster Cardiovascular Symposium, taking place Dec. 6-8 in Washington, DC. Explore sessions focused on heart failure such as:
Gain insights from world-renowned experts and connect with leaders in cardiovascular care – register today before it's too late!
SGLT2 inhibitors play an important role in preventing adverse cardiovascular events and improving outcomes in patients with heart failure, diabetes and chronic kidney disease.
Join your colleagues at ACC.25, taking place March 29-31, 2025, in Chicago, IL, and get the knowledge you need to transform cardiovascular care for all! You'll have the opportunity to discuss the latest science with top experts, learn how clinical guidelines translate into your daily practice, and build lasting connections with your peers. Register by Nov. 20 to SAVE up to $300 with early bird discounts and get all-inclusive access to ACC.25!
Transform the future of patient care by sharing your late-breaking clinical trial (LBCT) research with the global cardiovascular community at ACC.25, taking place March 29-31, 2025, in Chicago, IL.
The ACC is currently accepting submissions of abstracts, complex clinical cases and interventional challenging cases to be presented at ACC.25, taking place March 29-31, 2025, in Chicago, IL. Submit your research for a chance to transform the future of cardiovascular care by sharing your research with over 12,000 attendees from more than 130 countries. The deadline for all submissions is 1 p.m. ET on Tuesday, Oct. 1. Don't miss your chance to be part of ACC.25 — submit your abstract or case today!
Check out the first issue of JACC: Case Reports under Editor-in-Chief Gilbert H. L. Tang, MD, MSc, MBA, FACC, and his new editorial board. The issue contains a powerful viewpoint by Michael J. Daly, MA, MD, PhD, FACC, discussing his own doctor-as-patient story and his journey toward improved empathy. Plus, don't miss clinical cases and vignettes on micturition hypertension in an adolescent, acute coronary syndrome in a nine-year-old with homozygous familial hypercholesterolemia and more. Check out the full issue.
JACC: Heart Failure's latest issue focuses on the use of SGLT2 inhibitors in patients with heart failure both with and without type 2 diabetes. Each study is enhanced by a video where Javad Butler, MD, and the other authors talk through the key points and major findings. Additionally, don't miss a panel discussion where the authors delve deeper into the issues raised by their research. Learn more.
Hypertrophic cardiomyopathy (HCM) is the most common structural heart defects, yet it is often misdiagnosed or underdiagnosed. The HCM: Accelerating Guideline-Driven Care online course provides educational resources and activities to accelerate guideline-driven care and improve patient outcomes. Check out ACC's free PDF resources, HCM Pocket Guide, Essential EHR HCM Documentation and HCM Exercise Prescription which supporting clinician and patient decision-making surrounding the awareness, disease pathology, access to care, and latest science in managing HCM. Increase your competence in detecting and diagnosing HCM and stay up to date on new guidelines on the HCM: Accelerating Guideline-Driven Care online course.
Review the latest evidence, guidelines and clinical recommendations associated with CRT and practical clinical scenarios along the heart failure (HF) treatment continuum including when CRT should be considered with ACC’s free online course, Integrated Care Solutions for the CRT Patient.
Heart Failure (HF) Awareness Week is a nationwide campaign bringing awareness to the risk factors, signs, symptoms and treatment of HF.
Join ACC's Federal Cardiology Section on Wednesday, Feb. 28 at 7 p.m. ET for a discussion led by Daniel R. Schwartz, MD, FACC; Stephanie Hsiao, MD; and Carrie M. Puckett, DO, on heart failure (HF) management by left ventricular assist devices, transplantation and medical therapy/palliative care through a federal provider lens. Learn more.
Join your colleagues in Atlanta, April 6-8, for ACC.24 and explore the Heart Failure (HF) and Cardiomyopathies Learning Pathway for a comprehensive overview of the latest developments in the field of HF. Experts in the field will guide you through the most recent pharmacologic and device therapy breakthroughs in interactive and educational formats, leaving attendees with an enhanced understanding of the multidisciplinary care required for patients with HF. Register by March 6 to SAVE and learn more about all ACC.24 has to offer!
MedAxiom has released its annual Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report. Of the 106 survey participants, 83% reported that of APPs were involved in the delivery of heart failure (HF) care. Read the full report to learn about the importance of a team-based care model in the delivery of HF specialty care. Learn more.
ACC's online course, Heart Failure and SGLT2is: The New Pillar in Care, provides practical guidance for cardiologists on the implementation of SGLT2 inhibitors into treatment of patients with heart failure (HF). Participate in eight engaging lessons to change the trajectory of SGLT2i use. Plus, don't miss the podcasts, patient case quizzes and other educational tools and resources focusing on patient selection, dosing and other clinical considerations to improve outcomes for HF patients. Learn more.
Are you a cardiologist, surgeon or doctorate-level educated researcher interested in participating as an investigator and leader in cardiovascular clinical trials research? Apply by Friday, Jan. 12 to join the next cohort of the Clinical Trials Research Program and gain the tools you need to advance your career in clinical trial research. Selected participants will receive support for travel expenses and will be invited to write and submit an original research proposal to be considered for a one-year research award. Learn more and apply.
Hypertrophic cardiomyopathy (HCM) is the most common structural heart defects, yet it is often misdiagnosed or underdiagnosed. The HCM: Accelerating Guideline-Driven Care online course provides educational resources and activities to accelerate guideline-driven care and improve patient outcomes.
Looking to enhance your career and skills in clinical research? Apply to be a part of ACC's 2024 Clinical Trials Research: Upping Your Game program.
U.S. News & World Report recently released the 2024 edition of the "Best Hospitals" guidebook, featuring more than 2,000 hospitals, health systems and facilities participating in NCDR and ACC Accreditation Services.
JACC: Heart Failure is inviting submissions for a special focus issue on strategies for the management of obesity and heart failure (HF).
Join us virtually for Cardio-Obstetrics Essentials: Team-Based Management of Cardiovascular Disease and Pregnancy on Dec. 15. This interprofessional course is focused on providing a basic to intermediate level of education on the evolving field of cardio-obstetrics and will convene a uniquely qualified and diverse group of cardiologists, maternal-fetal specialists and cardio-obstetrics team members.
Join editorial board members from JACC: Heart Failure, JACC: Basic to Translational Science and JACC: CardioOncology during a Meet-and-Greet Reception during the HFSA Annual Scientific Meeting 2023.
To inform cardiovascular professionals on the latest findings surrounding heart transplant policy, JACC: Heart Failure has developed a multi-publication "bundle" on the topic of heart transplant allocation.
SGLT2 inhibitors (SGLT2is) are now a key pillar in the treatment with heart failure (HF). Adding an SGLT2i to standard HF therapy can cut the risk of cardiovascular death or HF hospitalization by one-third.
The ACC has released a “Meeting in a Box” on hypertrophic cardiomyopathy (HCM) diagnosis and treatment, which contains the tools needed to successfully host an educational activity.
ACC’s Heart Failure (HF) Accreditation applies a holistic approach to the assessment, treatment and management of the HF population, designed to improve the effectiveness and efficiency of each decision point while maintaining quality patient care and safe discharge.
In a recent ACC CardiaCast podcast series, James L. Januzzi Jr., MD, FACC, provides “behind the scenes” interviews with authors of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
Learn to identify guideline-driven heart failure care, treatment options, and practice considerations associated with delivering IV iron replacement therapy with ACC’s new online course, Iron Deficiency in Heart Failure.
The latest issue of JACC: Basic to Translational Science includes presentations from the Cardiovascular Research Foundation’s Technology and Heart Failure Therapeutics (THT) 2023 Shark Tank Innovation Competition.
If you are attending the Canadian Heart Failure Society’s (CHFS) Heart Failure Update 2023 (HFU23) in Toronto, join JACC: Heart Failure Editor-in-Chief Biykem Bozkurt, MD, PhD, FACC; Deputy Editor Akshay Desai, MD, FACC; and members of the editorial board for a meet-and-greet reception on Friday, May 12, from 5 to 6 p.m. ET.
The ACC is seeking a qualified candidate to serve as Writing Committee Chair for a new multi-societal advanced training statement on critical care cardiology.
In an article recently published in JACC, Anthony P. Carnicelli, MD, FACC, et al., note the need for cardiologists focused on critical care, the skills required to be a contemporary critical care cardiology specialist and example curriculum that could provide a new pathway for trainees to obtain the necessary skills to work in this rapidly growing subspeciality.
ACC’s Heart Failure and SGLT2is: The New Pillar in Care online course provides free, practical guidance on the implementation of SGLT2 inhibitors (SGLT2is) into treatment of patients with heart failure (HF).
The ACC is seeking a qualified candidate to serve as Writing Committee Chair for a new multi-societal advanced training statement on critical care cardiology.
Heart failure is a significant global epidemic; however, there may be sex-related differences in the epidemiology, pathophysiology, risk factors, and outcomes. To highlight the latest and most impactful science from the growing body of literature on this topic, JACC: Heart Failure will publish a new special issue in September of this year.
Attending ACC.23/WCC in New Orleans? Mark your calendars for these JACC Journals events!
Join your colleagues at ACC.23 Together With WCC for a comprehensive overview of the latest developments in the field of HF.
"PulseCheck" is a series within the CardiaCast podcast that is designed for nurses or allied health care professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day.
Join ACC’s Cardio-Obstetrics Work Group on Monday, Jan. 9 at 8 p.m. ET, for a webinar on the recent JACC: Advances article "The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy."
The U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health Resilient Supply Chain Program is conducting a survey in support of an interagency effort to develop a recommended list of critical medical devices – including device materials, components, parts, or accessories – to improve the nation’s preparedness for future emergencies and implement the National Strategy for a Resilient Public Health Supply Chain.
Beginning in January 2023, JACC: Heart Failure be published exclusively online, and all print publications of its sister journals will be discontinued.
Join ACC’s Chief Innovation Officer Ami B. Bhatt, MD, FACC; Regina Druz, MD, FACC, ChenMed’s national director of cardiology; and Maulik Majmudar, MD, chief medical officer and co-founder at Biofourmis, for a webinar on Wednesday, Nov. 30, at 6 p.m. ET to learn about leveraging innovation to promote value-based care, with a special focus on heart failure.
The Heart Failure (HF) and Cardiomyopathies Learning Pathway at ACC.23/WCC provides a comprehensive overview of the latest developments in the field of HF.
JACC: Heart Failure has released its first-ever article summary podcasts, highlighting articles from the November issue.
Join Matthew W. Martinez, MD, FACC; Michael J. Ackerman, MD, PhD, FACC; and Erica Spatz, MD, for Real-World Shared Decision Making Conversations: Sudden Cardiac Death in HCM in Stop 5: HCM Shared Decision Making: Conversations That Count.
In its continued effort to educate and empower the cardiovascular care team, MedAxiom, an ACC Company, developed the Cardiovascular Advanced Practice Provider (APP) Essential Education Series: Heart Failure (HF), available through the MedAxiom Academy.
Cardiac amyloidosis is a cardiomyopathy caused by the infiltration of protein amyloid in the myocardium and surrounding tissues and is often unrecognized and underdiagnosed. The ACC has created the Cardiac Amyloidosis: Accelerating Diagnosis and Treatment online course to build competence in timely detection and diagnosis of this rare condition.
ACC's Clinical Spotlight Series shines a light on best practices and emerging science across practice-changing topics in care including atrial fibrillation, lipid management and SGLT2 inhibitors in heart failure.
Perfect your knowledge of advanced heart failure and transplant cardiology with HF SAP. Not only can HF SAP help you identify knowledge gaps and reinforce existing knowledge, it can also be used for the Collaborative Maintenance Pathway (CMP) – an ACC and ABIM option for meeting Maintenance of Certification (MOC) requirements in Advanced Heart Failure and Transplant Cardiology.
The full Route HCM online course is available now! Join Matthew W. Martinez, MD, FACC, Michael J. Ackerman, MD, PhD, FACC, and Erica Spatz, MD, for Real-World Shared Decision Making Conversations: Sudden Cardiac Death in HCM in Stop 5: HCM Shared Decision Making: Conversations That Count.
Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular diseases. The good news is HCM is highly treatable once it is recognized. The HCM: Accelerating Guideline-Driven Care online course provides educational resources to improve patient outcomes.
Virtually join ACC's inaugural Cardio-Obstetric Essentials: Team-Based Management of Cardiovascular Disease and Pregnancy course on Nov. 18!
The Clinical Spotlight Series shines a light on best practices and emerging science across practice-changing topics in care including SGLT2 inhibitors, heart failure, lipid management, and anticoagulation.
The first issue of JACC: Heart Failure under new Editor-in-Chief Biykem Bozkurt, MD, PhD, FACC, and the new editorial board is now live.
Now is the best time to take advantage of the Collaborative Maintenance Pathway (CMP) – an alternative option offered by the ACC and the American Board of Internal Medicine (ABIM) for meeting maintenance of certification (MOC) requirements, as well as all other education, licensure and certification needs.
When it comes to meeting maintenance of certification (MOC) requirements, you have choices! With the Collaborative Maintenance Pathway (CMP), there is no need to take a comprehensive exam covering the breadth of your field.
JACC: Case Reports is inviting submissions for a 2022 special themed issue on long COVID cardiac cases. Papers in the form of clinical cases, clinical case series and clinical vignettes will be accepted.
The ACC's Accelerating Innovation for Medical Excellence in Hypertrophic Cardiomyopathy (AIME HCM) initiative is designed to amplify education, research efforts, clinical guidance and practical tools to increase awareness and understanding of hypertrophic cardiomyopathy and optimize treatment and outcomes.
Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular diseases. The good news is HCM is highly treatable once it is recognized. Part of the Accelerating Innovation for Medical Excellence in Hypertrophic Cardiomyopathy (AIME HCM) initiative, this online course will ease the challenge of adopting new ACC/AHA guidelines and simplify the patient journey.
When it comes to meeting maintenance of certification (MOC) requirements, you have choices! If you’re due for an MOC assessment this year, the Collaborative Maintenance Pathway (CMP) is an MOC assessment option that helps meet ALL your needs!
Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular diseases. The good news is HCM is highly treatable once it is recognized. Part of the Accelerating Innovation for Medical Excellence in Hypertrophic Cardiomyopathy (AIME HCM) initiative, this online course will ease the challenge of adopting new ACC/AHA guidelines and simplify the patient journey.
The new issue of JACC: Basic to Translational Science includes a focus issue highlighting innovative presentations given as part of the Cardiovascular Research Foundation’s inaugural 2022 Technology for Heart Failure Therapeutics (THT) Shark Tank innovation competition.
Now is the best time to take advantage of the Collaborative Maintenance Pathway (CMP) – an alternative option offered by the ACC and the American Board of Internal Medicine (ABIM) for meeting maintenance of certification (MOC) requirements, as well as all other education, licensure and certification needs.
The ACC is excited to announce the launch of its new Critical Care Cardiology Member Section! Where once the coronary care unit treated primarily patients with acute coronary syndrome, modern cardiac intensive care units (CICU) care for much more diverse group of patients with cardiac and noncardiac critical illnesses.
The last Collaborative Maintenance Pathway (CMP) Performance Assessment window this year for HF SAP, is taking place Dec. 8 – 14.
ACC’s Geriatric Cardiology Section invites you to join the authors of the REHAB-HF trial on Wednesday, Dec. 1 at 6 p.m. ET, to examine the importance of early rehabilitation among older adults hospitalized for acute decompensated heart failure.
Meet your education, licensure and certification requirements with the Collaborative Maintenance Pathway (CMP).
Cardiac amyloidosis is a cardiomyopathy caused by the infiltration of protein amyloid in the myocardium and surrounding tissues and is often underdiagnosed.
The ACC created the Hypertrophic Cardiomyopathy: Accelerating Guideline-Driven Care online course to provide hypertrophic cardiomyopathy (HCM) educational resources and activities to accelerate guideline-driven care and improve patient outcomes.
ACC's Scientific Publications Committee is seeking applications for the position of Editor-in-Chief of JACC: Heart Failure, a monthly subspeciality journal encompassing the most important findings on the pathophysiology, diagnosis, treatment and care of heart failure patients.
Pulmonary hypertension is a fatal disease with no specific symptoms that is often neglected. Evidence from Asia has greatly contributed to significant developments in the understanding and management of pulmonary hypertension and right heart failure over the past five years.
Diabetes is a significant risk factor for heart failure (HF) and a common debilitating comorbidity. New research is leading to a better understanding of these comorbid conditions and improved care and outcome for patients. JACC: Heart Failure has published a special issue dedicated to the topic of HF and diabetes.
Join the ACC Fellows in Training and Heart Failure and Transplant Sections for a webinar on Tuesday, July 27, at 7 p.m. ET.
The ACC has created a free, online course: Raising Awareness and Understanding of Cardiac Amyloidosis to improve clinicians’ understanding of cardiac amyloidosis, which is often not recognized and underdiagnosed.
Did you know? You now have the option to use HF SAP to maintain your American Board of Internal Medicine (ABIM) certification through the Collaborative Maintenance Pathway (CMP).
In a new collaboration with Medscape, the ACC has created the Heart Failure Center of Excellence to extend the reach of expert information and improve patient care.
Have thoughts about the Late Breaking Clinical Trials and Hot Topics? We want to hear them!
Join the ACC's CV Disease in Women Committee on Sunday, April 25 at noon ET for a can't-miss, cardiology fact-based competition featuring legends in the field of heart disease in women.
The ACC and American Heart Association (AHA) have released the 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure.
Diabetes is a significant risk factor for heart failure and a common debilitating comorbidity. New emerging therapies and a better understanding of this comorbid condition can assist clinicians in improving care and outcomes for these patients. JACC: Heart Failure is focusing on the growing body of literature with a special issue on this topic planned for August.
Join the ACC in recognizing Heart Failure (HF) Awareness Week from Feb. 14 – 20 as part of American Heart Month.
The ACC has released an updated Expert Consensus Decision Pathway providing guidance and recommendations on streamlining clinical care to achieve optimal outcomes for patients with heart failure with reduced ejection fraction (HFrEF).
A significant risk factor for heart failure, diabetes is a common debilitating comorbidity. New emerging therapies and a better understanding of this comorbid condition can assist clinicians in improving care and outcomes for these patients.
Catch up on the recent JACC: Heart Failure Virtual Journal Club during which Editor-in-Chief Christopher O'Connor, MD, MACC; authors G. Michael Felker, MD, MHS, FACC, and John J.V. McMurray, MD, FACC; and Journal editors discussed the manuscript, "Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study."
JACC: Heart Failure recently co-published "Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium (HF-ARC)" with the European Journal of Heart Failure.
The British Society for Heart Failure Autumn meeting, taking place virtually Nov. 26 – 27, will feature a keynote lecture highlighting the JACC: Heart Failure state-of-the-art review, Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF.
A new measure set to evaluate heart failure (HF) care in the inpatient and outpatient settings was released Nov. 2 and published in the Journal of the American College of Cardiology.
Caring for vulnerable populations presents some unique challenges. It also offers immense opportunities for innovation to effect positive change for many lives.
Journal Editor-in-Chief Christopher M. O’Connor, MD, MACC, members of the Journal editorial board and expert panelists for a Virtual Journal Club on Friday, Oct. 30, from 12-12:45 p.m. ET for a discussion on a recently published manuscript further examining the findings of the VICTORIA Study.
Transendocardial injection of allogeneic mesenchymal stromal cells (allo-MSCs) may be safe and feasible in patients with anthracycline-induced cardiomyopathy (AIC), according to findings from the SENECA trial presented Sept. 30 during the Heart Failure Society of America Virtual Annual Scientific Meeting 2020 and simultaneously published in JACC: CardioOncology.
Journal Editor-in-Chief Christopher M. O'Connor, MD, MACC, members of the Journal editorial board and authors will welcome live participants for the next JACC: Heart Failure Virtual Journal Club on Thursday, Sept. 24 from 12 – 12:45 p.m. ET.
Addressing the COVID-19 pandemic requires a coordinated plan that balances quality patient care with the safety of health care workers, all while maintaining consistent access to care for patients with and without COVID-19.
ACC's new CardioSmart website is designed to emphasize the value of the patient and clinician partnership to personalize care. With the goal of better connecting patients with their clinicians to prevent or treat heart disease, the new CardioSmart.org, provides information on heart conditions and trusted resources and tools to support important health conversations and foster a strong partnership.
Temporary mechanical circulatory support (MCS) is an attractive and intuitive option when medical approaches to supporting a weakened heart are insufficient. But while the field is a growing one, it is also one that has produced a jumbled evidence base for a range of devices and a smattering of indications.
Recordings and key takeaways from two recent JACC: Heart Failure Virtual Journal Clubs are now available.
The newly released 2019 Journal Citation Report for Cardiac and Cardiovascular Systems ranks four JACC Journals in the top 12 among all 141 English-language cardiovascular journals. JACC is celebrating an impressive threshold, passing an Impact Factor of 20 and an overall rank of third among cardiovascular journals worldwide.
Don't miss the June JACC: CardioOncology Patient Perspective Podcast. Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, talks with husband and wife physicians, Jagmeet P. Singh, MD, PhD, FACC, and Noopur Raje, MD, about their personal experience with COVID-19.
The newly published issue of JACC: CardioOncology features an impressive lineup of content on heart failure and pregnancy in cancer survivors; imaging cardio-oncology; strain in AL Amyloidosis; CAR T therapy; cardiac monitoring in HER2+ therapy; resiliency in cardio-oncology; and more.
Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, will host the inaugural JACC: CardioOncology Virtual Journal Club on Tuesday, June 30 from 10 – 11 a.m. ET.
JACC: Heart Failure is now accepting submissions for a themed issue highlighting cardiogenic shock, to publish this November.
Explore the unique risk factors for cardiovascular disease in women – as well as prevention and treatment strategies – when you register for an ACC live webinar on June 18.
Join Journal Editor-in-Chief Christopher M. O'Connor, MD, MACC; Eugene Braunwald, MD, MACC; Douglas L. Mann, MD, FACC; and members of the Journal editorial board for the next live JACC: Heart Failure Virtual Journal Club on Thursday, June 18, from 12 – 12:30 p.m. ET.
Join Editor-in-Chief Christopher M. O'Connor, MD, MACC, Journal editors and authors for live JACC: Heart Failure Virtual Journal Club on Thursday, May 14, from 6 – 7:30 p.m. ET.
The ACC is seeking comments on a draft of the 2020 ACC/AHA Key Data Elements and Definitions for Heart Failure.
In a new Editor's Page published in the Journal of the American College of Cardiology (JACC), Editor-in-Chief Valentin Fuster, MD, PhD, MACC, and Justine Turco, ACC's divisional senior director of publishing, provide a look on how COVID-19 has impacted clinical care and peer-review publishing.
A newly accepted JACC: Heart Failure manuscript addresses a possible missing link between COVID-19 illness and heart failure and the various concerns heart failure specialists face when treating COVID-19 patients. Authors Mandeep R. Mehra, MBBS, FACC, and Frank Ruschitzka, MD, outline the current evidence informing whether the use of drugs prescribed for comorbidities, such as hypertension and diabetes mellitus, should be continued in these patients who go on to manifest the highest risk for complications with COVID-19.
The latest issue of JACC: Case Reports highlights clinical cases to inform the care of heart failure patients.
The ACC, the Heart Failure Society of America and the International Society for Heart and Lung Transplantation have released the 2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists Feb. 17 in the Journal of the American College of Cardiology.
Network with your peers at the Heart Failure Section Meeting and Career Symposium, taking place March 28 at 6 p.m. CT at the Marriott Marquis Chicago, at ACC.20/Together With World Congress of Cardiology (ACC.20/WCC).
The ACC is seeking comments on a draft of the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults with Heart Failure.
JACC: Heart Failure is seeking submissions for a themed issue highlighting cardiogenic shock to publish this November. The issue will examine the evolution of new therapies and novel treatment approaches for cardiogenic shock.
Join the ACC in recognizing Heart Failure (HF) Awareness Week from Feb. 9 – 15 as part of American Heart Month. CardioSmart's new Heart Failure Action Plan provides information for patients to better understand their condition, resources to find support, questions to ask their physicians, and more.
Chili Pepper Consumption and Mortality in Italian Adults by Marialaura Bonaccio, PhD, et al. received the most online attention among research published in the Journal of the American College of Cardiology (JACC) in 2019.
The highly anticipated second issue of JACC: CardioOncology features an impressive lineup of original research, reviews and case challenges on topics such as hypertension in cancer patients and survivors, ATTR amyloid, ischemia and bleeding in cancer patients undergoing PCI, cardiovascular prevention strategies in breast cancer and more.
The multi-faceted Improving Heart Failure Outcomes Through Personalized Education (HOPE) curriculum from the ACC and Haymarket Medical Education consists of 30 live and online certified education activities to help health care professionals improve heart failure (HF) patient care and outcomes.
ACC's newest JACC Journal, JACC: CardioOncology, will publish its second issue on Tuesday, Dec. 17. The highly anticipated second issue will be feature state-of-the-art reviews, primers, research letters, viewpoints and case challenges on topics such as ischemia and bleeding in cancer patients undergoing PCI, hypertension in cancer patients and survivors, increased cancer prevalence in peripartum cardiomyopathy, and much more.
The newest issue of JACC: Heart Failure brings together the latest research on heart failure in the elderly. Examining differences in treatment effects, treatment options, epidemiology, pathophysiology, risk factors and outcomes that are significant in the elderly population, this issue aims to grow the body of literature surrounding this important and emerging theme.
There are a lot of big ways to get involved with the College – being on a Section Leadership Council, participating on a taskforce or committee, or serving as faculty for a live course, to name a few. However, we know that not everyone has the time for some of these larger-scale commitments. That's why the ACC is excited to announce the launch of our Microvolunteering Platform.
Applications are now being accepted for the ACC Leadership Academy Cohort IV, which will launch at ACC.20/World Congress of Cardiology in Chicago, IL.
Join world-renowned cardiologist and course director Valentin Fuster, MD, PhD, MACC, at ACC's New York Cardiovascular Symposium, taking place Dec. 6 – 8.
ACC's new Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized with Heart Failure addresses unresolved issues in patients hospitalized with heart failure (HF).
ACC's CardioSmart team recently developed a suite of tools and resources to help patients with heart failure begin managing their condition and know what to expect. Help your patients reach their goals with the "I Have Heart Failure With Reduced Ejection Fraction. Now What?" My Heart Failure Action Plan.
For AFib Awareness Month, take advantage of ACC's latest atrial fibrillation (AFib) resources. The AFib Shared Decision Making Tools help patients with AFib decide whether to mitigate their risk of stroke with blood thinners. Use the Stroke and Bleeding Risk Calculator together with the decision aids to find the right treatment for your patients. ACC's CardioSmart team also offers additional resources to help your patients understand this condition, including the free AFib, Stroke and Blood Thinners infographic.
Cardiology is the ACC's flagship member magazine — your member magazine — providing cardiovascular professionals with a comprehensive source for clinical and professional news. Find links to all of the July issue's articles and share on social media!
The ACC has made a select number of travel awards available to cover expenses for members to travel to ACC's 2019 Legislative Conference, Nov. 3 – 5, in Washington, DC.
The ACC is seeking a qualified and enthusiastic individual for the position of co-editor of Heart Failure SAP – a new self-assessment program on heart failure that will be released in 2020.
The National Heart, Lung, and Blood Institute (NHLBI) is inviting comments on the potential development of a Challenge Prize for Heart Failure (HF) Phenotyping.
Aiming to grow the body of literature surrounding the important and emerging theme of heart failure in the elderly, JACC: Heart Failure will publish a special issue on the topic this December.
Get a unique perspective on ACC.19 by following this year's Learning Pathway Tweeters.
Join the ACC in recognizing Heart Failure (HF) Awareness Week from Feb. 10 – 16 as part of American Heart Month.
Join us at the ACC.19 All-Section Reception, March 17, from 6:30 p.m. – 8 p.m., at the Hilton New Orleans Riverside, Grand Ballroom A.
Take advantage of free, online certified educational activities to fulfill your 2018 CME requirements and earn MOC credit at the same time!
Myia Labs Inc., recently announced it has secured seed funding to accelerate development of its intelligent health monitoring platform. The ACC is collaborating on the platform as part of its Innovation efforts.
In the latest issues of Cardiology, deep-dive into the emerging risk factors of gestational hypertension and preeclampsia.
In this deep-dive video discussion, Valentin Fuster, MD, PhD, MACC; Deepak L. Bhatt, MD, MPH, FACC; Anne B. Curtis, MD, FACC; Peter Libby, MD, FACC; and Marc Ruel, MD, MPH, share their perspectives on the most significant science released during AHA.18.
The ACC has developed several Shared Decision-Making tools to help patients and clinicians work together when deciding on certain treatment options.
An innovative eight-part Cardiovascular Health Promotion Series published in the Journal of the American College of Cardiology (JACC) provides health care professionals with an in-depth examination of the eight risk factors and behaviors that contribute most to cardiovascular disease development.
The September 2018 issue of Cardiology, YOUR member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
JACC: Heart Failure will publish a special issue in March 2019 on the growing body of literature surrounding heart failure in women.
ACC.19 registration is NOW OPEN exclusively for ACC members. Nonmember registration will open Wednesday, Sept. 26. Register early for the lowest rates and best selection of hotel rooms!
While heart failure is an uncommon complication of breast cancer treatment, the risk may be higher in patients treated with certain types of chemotherapy and lower in younger patients, according to a study published Aug. 6 in JACC: Cardiovascular Imaging.
A series of eight state-of-the-art reviews is now publishing in the Journal of the American College of Cardiology (JACC). One review is publishing each week, examining the top risk factors affecting the cardiovascular health of patients: diet, tobacco, lipid control/cholesterol, blood pressure, psychological health, weight, physical activity and blood sugar.
On Valentine’s Day 1994, I was 5 years old and carefully crafting a card for my grandparents in art class. I remember gluing a white lace heart onto a red sheet of construction paper, excited to share my masterpiece. My grandfather picked me up from the bus stop that afternoon. Once home, he held his chest and reported pain. He tragically died in route to the hospital from a massive myocardial infarction at the age of 61. While I cannot recall if my grandfather’s early death was the impetus for my longstanding aspiration to become a cardiologist, it undoubtedly influenced my interest in preventive cardiology.
The August 2018 issue of Cardiology, YOUR member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
The ACC.18 Meeting Coverage Page on ACC.org features post-meeting content from the Heart Failure and Cardiomyopathies Learning Pathway to reinforce the teaching points and education presented during ACC.18. Catch up on the COMPASS trial and MORE.
The ACC.18 Meeting Coverage Page on ACC.org features post-meeting content from the Heart Failure and Cardiomyopathies Learning Pathway to reinforce the teaching points and education presented during ACC.18.
By embracing a domain-management approach that addresses unique multidimensional needs and vulnerabilities, clinicians may improve health outcomes for older adults with heart failure (HF), according to an ACC Geriatric Council Perspective published in the Journal of the American College of Cardiology.
The ACC.18 Meeting Coverage Page on ACC.org now features post-meeting content that is meant to reinforce the teaching points and education presented during ACC.18 from the Heart Failure and Cardiomyopathies Learning Pathway.
People who have both Type 2 diabetes and heart failure (HF) may have a lower risk of death or hospitalization for HF if they take an aspirin each day, according to research that will be presented at ACC.18 in Orlando. However, aspirin use in these patients could also increase the risk of a nonfatal heart attack or stroke.
Patients with a history of breast cancer or lymphoma may be more than three times as likely to develop heart failure (HF), according to research that will be presented at ACC.18 in Orlando.
Please join us for this year's Careers in Heart Failure & Transplant Symposium during ACC.18. The event will take place on Saturday, March 10th, 2018 at the Hyatt Regency Orlando, Regency Ballroom Q at 4:30pm-6:00pm.
Join the ACC in recognizing Heart Failure (HF) Awareness Week from Feb. 11 – 17 as part of American Heart Month. CardioSmart’s HF Condition Center provides information for patients to better understand their condition, resources to find support, questions to ask their physicians and more.
Heart failure with preserved ejection fraction represents a large and growing population of heart failure patients today. JACC: Heart Failure is focusing on the growing body of literature with a special issue on this topic.
In the latest ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC, is joined by Deepak L. Bhatt, MD, MPH, FACC; Rachel J. Lampert, MD, FACC; Prediman K. Shah, MD, MACC; and Chadwick W. Stouffer, MD, in a roundtable discussion of the hottest trials from AHA 2017 in Anaheim, CA. Among the trials discussed are DACAB, CANVAS, EXSCEL, POISE-2 and more.
The ACC, along with the American Heart Association and the Heart Rhythm Society, have published new guidelines for the treatment of adult patients with ventricular arrhythmias (VA) or who are at risk for sudden cardiac death. The new guidelines replace the 2006 ACC/AHA/SC Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death and provide recommendations regarding general evaluation of patients with documented or suspected VA; treatments, therapies and prevention of VA; acute management of specific VA; and VA in the structurally normal heart.
Surveys assessing the physician work necessary to perform (1) leadless pacemaker implantation and explantation, (2) pulmonary wireless monitor implantation and management and (3) pediatric thermodilution studies are being distributed to members throughout the month of October. If you are randomly selected and receive a survey, please take 15 – 30 minutes to thoughtfully complete it. Annual updates to the physician work relative values are based on recommendations from the Relative Value Scale Update Committee (RUC).
The ACC, Heart Failure Society of America (HFSA), Heart Rhythm Society (HRS) and Society for Cardiovascular Angiography and Interventions (SCAI) have announced a partnership to develop new modules to help subspecialty cardiologists potentially meet collaborative maintenance pathway requirements equivalent to satisfying the American Board of Internal Medicine’s (ABIM’s) current 10-year maintenance of certification (MOC) examination.
In conjunction with the ACC Committee Nominations cycle, the College’s Membership Committee is now accepting applications through Sept. 22. The Membership Committee was established as part of the 2015 College’s governance transformation and serves as standing committee of the College, reporting directly to the Board of Trustees.
The August 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
The July 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
The ACC is seeking qualified candidates to serve as vice chair of the Annual Scientific Session for a two-year term of office for ACC.19 and ACC.20, moving on to assume another two-year term as chair of ACC.21 and ACC.22.
The ACC.org editors have created additional heart failure (HF) and cardiomyopathies-related content meant to reinforce the teaching points and education presented during ACC.17.
As the 50th anniversary of the first human heart transplant approaches, JACC: Heart Failure is honoring this milestone with a special issue focused on the topic of cardiac transplantation. This uniquely themed issue will highlight the role of cardiac transplantation, as well as the care of patients pre- and post-transplant.
The ACC recently launched a Heart Failure Discussion Guide to help guide conversations between clinicians and patients about HF treatments in order to optimize outcomes. For additional clinical tools and resources, check out the College’s Heart Failure Practice Solutions clinical toolkit and ACC’s Succeed in Managing Heart Failure Initiative.
After approving a new specialty designation for "Advanced Heart Failure (HF) and Transplant Cardiology" at the end of 2016, the Centers for Medicare and Medicaid Services (CMS) has completed the necessary steps to create the code and make it available for physicians to use in their provider enrollment. The new code will become effective Oct. 1.
The June 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
The ACC.org editors have created additional heart failure (HF) and cardiomyopathies-related content meant to reinforce the teaching points and education presented during ACC.17.
The ACC recently launched a Heart Failure Discussion Guide to help guide conversations between clinicians and patients about HF treatments in order to optimize outcomes.
The ACC, along with the American Heart Association (AHA) and the Heart Failure Society of America (HFSA), have released a focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.
The ACC.org editors have created additional heart failure (HF) and cardiomyopathies-related content meant to reinforce the teaching points and education presented during ACC.17.
After approving a new specialty designation for "Advanced Heart Failure and Transplant Cardiology" at the end of 2016, the Centers for Medicare and Medicaid Services (CMS) has completed the necessary steps to create the code and make it available for physicians to use in their provider enrollment.
The ACC is seeking comments on a draft of the Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment. This document will serve as a complement to the 2013 ACC/AHA Guideline for the Management of Heart Failure, and the 2016/2017 focused updates addressing new medical therapies, prevention and certain co-morbidities for which new data are available.
The Centers for Medicare and Medicaid Services (CMS) convened a Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) meeting March 22 to inform future decision-making on coverage of heart failure (HF) technologies. The panel of physicians and other experts voted on questions considering which types of outcomes are useful for evaluating HF technology studies.
Attending ACC.17? Join us for the All-Section Meeting & Reception at ACC.17! The event happening THIS Saturday, March 18, 2017 from 6:00 p.m. – 7:30 p.m. at the Marriott Marquis will give you a chance to learn more about what ACC's 19+ Member Sections are working to accomplish and to connect with members in your specialty or interest areas.
A new training statement from the ACC and numerous partnering societies addresses the competencies required of sub-subspecialists in Advanced Heart Failure and Transplant Cardiology (AHFTC). The document was published March 8 in the Journal of the American College of Cardiology.
Save the Date for the All-Section Meeting & Reception at ACC.17! Happening on Saturday, March 18, 2017 from 6:00 p.m. – 7:30 p.m. at the Marriott Marquis, this event will give you a chance to learn more about what ACC’s 19+ Member Sections. Submit your RSVP to attend.
The JACC: Heart Failure website has been redesigned, bringing a fresh perspective to the journal’s vast content – and helping clinicians stay on top of the most important science and emerging discoveries in clinical cardiology.
After great effort by the Heart Failure Society of America and the ACC, the Centers for Medicare and Medicaid Services (CMS) informed both societies that a new specialty designation for “Advanced Heart Failure and Transplant Cardiology” has been approved.
Join a panel of speakers on Monday, Dec. 12 at 8:00 p.m. ET to hear about preventive medicine along with lifestyle modification, including adopting and/or adhering to a heart healthy diet, regular exercise habits, avoidance of tobacco products, and achieving or maintaining a healthy weight.
The latest ACC Journal Club discussion is now available online. Click here to view slides and hear experts discuss “Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization,” published in the Journal of the American College of Cardiology.
In the U.S., an estimated 14.5 million individuals have a history of cancer, representing a prevalent and rapidly growing population. Given this staggering statistic, clinicians often encounter patients with cancer and cancer survivors who have significant cardiovascular risk factors and cardiovascular disease.
The newest version of the Heart Failure (HF) Accreditation tool – HF v3 – is targeted for availability later this summer. The new version offers two separate designations – one for facilities that transfer or refer patients for transplant or other more advanced types of mechanical circulatory support and another for facilities that meet the criteria established for management of more advanced HF.
For the third year in a row, the Journal of the American College of Cardiology (JACC) ranked as the #1 cardiovascular journal in the world. According to the 2015 Impact Factors for Journals, JACC holds the top position among all 124 cardiovascular journals in scientific impact with its highest impact factor ever of 17.759, up from 16.503 in 2014.
The ACC/AHA Task Force on Performance Measures has developed a prevention of sudden cardiac death measure set. The Task Force is seeking public comments on the measure set. Before completing the survey, please review the draft prevention of sudden cardiac measure set. To provide comments, please access the survey here. If you need to exit the survey before you have finished commenting, you can save your responses and return to the survey later.
Extensive training, expert treatment and board tests are all requirements for becoming a sub-specialized cardiologist. Physicians take pride in their distinct area of practice and are sought out by patients and referring practitioners looking for skilled care.
As part of its ongoing strategic focus on purposeful education, the American College of Cardiology’s (ACC) Competency Management Committee has drafted the ACC Lifelong Learning Competencies for General Cardiologists. The Committee is seeking public comments on the draft which is the first document of its kind to combine medical knowledge, patient care and procedural skill competencies across 18 clinical areas in conjunction with administrative, leadership, and professional competencies.
In response to input provided by the ACC and other cardiology specialty societies (SCAI, HRS and HFSA) around the American Board of Internal Medicine’s (ABIM’s) new requirements for Maintenance of Certification (MOC), the ABIM today announced it is eliminating the requirement to maintain underlying certification in a foundational discipline in order to remain certified in a subspecialty.
Did you know there are 20 Clinical Topic Collections on ACC.org, with editorial boards creating content every week? In each Clinical Topic Collection, you can find the latest news, guidelines, JACC articles, education, expert commentary, and more.
The cover story in a recent issue of Cardiology magazine provides an in-depth look at big data and its implications on the future of medicine. It also features an article about the CardioEncounters program, a new approach to patient-clinician interactions, and includes an exclusive interview with the new U.S. Food and Drug Administration Commissioner for Medical Products and Tobacco Robert Califf, MD, MACC.
